Studies on the antimicrobial activity of cecropin A-melittin hybrid peptides in colistin-resistant clinical isolates of Acinetobacter baumannii

The Journal of Antimicrobial Chemotherapy
María Jesús Rodríguez-HernándezJerónimo Pachón

Abstract

Acinetobacter baumannii has successfully developed resistance against all common antibiotics, including colistin, one of the last active drugs against this pathogen. We have tested whether the differences in lethal mechanism between polymyxin B and the cecropin A-melittin hybrid peptide CA(1-8)M(1-18), shown previously with a colistin-susceptible strain, can be exploited as a new chemotherapeutic alternative against colistin-resistant clinical isolates. Furthermore, the effect of capsule on the bactericidal activity of cecropin A-melittin analogues (CAMs) was tested. MICs and MBCs of the four CAMs were determined for 13 clinical isolates. The bactericidal activity of the antimicrobial peptides was measured using time-kill curves. The presence or absence of capsule was determined using Indian ink stain. The MIC ranges of CA(1-8)M(1-18) and three of its shortened analogues, namely CA(1-7)M(2-9), its Nalpha-terminal octanoylated analogue and CA(1-7)M(5-9), for A. baumannii strains were 2-8, 2-4, 2-8 and 4-4 mg/L, respectively. MBCs differed by a factor of two at the most. All of the cecropin A-melittin peptides showed bactericidal activity in time-kill curves against four A. baumannii strains. The bactericidal activity of CAMs was...Continue Reading

Citations

May 26, 2010·Applied Microbiology and Biotechnology·Xue-mei LuXiao-bo Li
Apr 12, 2011·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·R López-RojasJ Pachón
Mar 24, 2012·The Journal of Antimicrobial Chemotherapy·Yun CaiNan Bai
Aug 19, 2007·Journal of Pharmaceutical Sciences·Lisa M RossiGeorge Y Wu
Mar 6, 2009·Journal of Drug Targeting·Xinke ZhangGuihua Huang
Jun 3, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·Frédéric TewesJean-Christophe Olivier
Oct 6, 2012·Expert Opinion on Pharmacotherapy·Jordi Vila, Jerónimo Pachón
Mar 4, 2008·Expert Opinion on Pharmacotherapy·Jordi Vila, Jerónimo Pachón
Jan 23, 2013·Pharmaceutical Development and Technology·Yumeng Wei, Ling Zhao
Jan 16, 2013·Trends in Microbiology·Meritxell García-QuintanillaMichael J McConnell
Jun 16, 2011·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·X Vila-FarresJ Vila
Apr 14, 2016·Expert Opinion on Pharmacotherapy·Younes SmaniJerónimo Pachón
Jul 13, 2017·Journal of Medical Microbiology·Zohreh Mohammadi AzadMehrdad Moosazadeh Moghaddam
Sep 30, 2020·International Journal of Molecular Sciences·Katrina BrowneNaresh Kumar
Feb 7, 2008·Expert Review of Anti-infective Therapy·George H Talbot
Mar 13, 2021·Chemical Society Reviews·Wenyi LiJohn D Wade
Aug 28, 2021·International Journal of Molecular Sciences·Nunzianna DotiAndrea Caporale
Sep 14, 2021·PloS One·Sirirak ArthithanyarojAmornrat Aroonnual

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.